stockmarketproxy
/
BDXNYSE SEC EDGAR

BECTON DICKINSON & CO

Surgical & Medical Instruments & Apparatus·FRANKLIN LAKES, NJ·FY end 09/30·CIK 10795
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$21.8B$20.2B$19.4B$18.9B$20.2B
Gross Profit——————
Operating Income$2.6B$2.4B$2.1B$2.3B$2.8B
Net Income$1.7B$1.7B$1.5B$1.8B$2.1B
Operating CF————$4.6B—
Capex$760.0M$725.0M$874.0M$973.0M$1.2B
Free Cash Flow————$3.4B—
Buybacks$1.0B$500.0M$0$500.0M$1.8B
Dividends$1.2B$1.1B$1.1B$1.1B$1.0B
Gross Margin——————
Operating Margin11.8%11.9%10.9%12.1%13.8%
Net Margin7.7%8.4%7.7%9.4%10.3%
FCF Margin————16.9%—
R&D / Revenue5.8%5.9%6.4%6.7%6.6%
Effective Tax10.8%15.0%7.9%8.3%6.7%
Debt / Equity0.690.690.570.550.72
Buybacks / FCF————51.2%—

Peer comparison

Surgical & Medical Instruments & Apparatus · 5 peers
CEO Pay Ratio
BDX
374:1
BSX
348:1
SYK
264:1
MMM
316:1
PODD
213:1
BAX
257:1
CEO total comp
BDX
$17M
BSX
$24M
SYK
$21M
MMM
$21M
PODD
$19M
BAX
$18M
Net Margin
BDX
7.7%
BSX
—
SYK
11.8%
MMM
13.0%
PODD
9.1%
BAX
-8.5%